MARISSA HOGAN: Open Payments
NPI 1639621121 · POCAHONTAS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 20 payments from 11 companies in 2025. Trend: 2023 $407 · 2024 $258 · 2025 $314
Food & beverage: $314
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $84 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| Verona Pharma, Inc. | 2 | $29 |
| Lundbeck LLC | 1 | $28 |
| ABBVIE INC. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
| Exact Sciences Corporation | 1 | $16 |
| PFIZER INC. | 1 | $14 |
Products named: REXULTI, OTEZLA, CAPLYTA, Ohtuvayre, UBRELVY, Rybelsus, AIRSUPRA, The Cologuard Plus Collection Kit.
Industry payments across AR — which companies pay providers there.
